Julie Brahmer
MD, MSc
Professor of Oncology, Director Thoracic Oncology
👥Biography 个人简介
Julie Brahmer led the first studies of nivolumab in NSCLC and has contributed to foundational trials of checkpoint blockade including perioperative regimens. She directs thoracic oncology at Johns Hopkins and shapes NCCN lung cancer guidelines. Her career has defined modern NSCLC immunotherapy.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Julie Brahmer 的研究动态
Follow Julie Brahmer's research updates
留下邮箱，当我们发布与 Julie Brahmer（Johns Hopkins Sidney Kimmel Comprehensive Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment